DR. MARCEL MOHR (he/him)
VERÖFFENTLICHUNGEN
Beiträge in Fachzeitschriften
- C. Trovato, M. Mohr, F. Schmidt, E. Passini, B. Rodriguez. Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac Purkinje cells for proarrythmia risk prediction. Front. Toxicol. 4:992650 (2022).
ausgezeichnet mit dem Translational Safety Publication Award 2024 der Safety Pharmacology Society - M. Mohr, J. M. Chambard, V. Ballet, F. Schmidt. Accurate in silico simulation of the rabbit Purkinje fiber electrophysiological assay to facilitate early pharmaceutical cardiosafety assessment: Dream or reality? J. Pharmacol. Toxicol. Methods 115: 107172 (2022).
ausgezeichnet mit dem Translational Safety Publication Award 2022 der Safety Pharmacology Society
ausgezeichnet mit dem Model of the Year 2024 Preis des EMBL-EBI - M. Mohr, D. Hose, A. Seckinger, A. Marciniak-Czochra. Quantification of plasma cell dynamics using mathematical modelling. R. Soc. Open Sci. 5: 170759 (2018)
- M. Mohr, M. V. Barbarossa, C. Kuttler. Predator-prey interactions, age structures and delay equations. Math. Model. Nat. Phenom. 9(1): 92-107 (2014)
Monografien
- M. Mohr. Mathematical modelling of plasma cell dynamics in multiple myeloma. Dissertation, Universität Heidelberg (2016)
- M. Mohr. On predator-prey models with delay due to maturation. Master Thesis, Technische Universität München (2012)
- M. Mohr. Das N-Wirbel-Problem. Bachelor Thesis, Universität Gießen (2009)
Konferenz-Beiträge
- M. Mohr, K. Waese, Z. Li, A. Hohlbaum, F. Schmidt. Prediction of drug-induced hematotoxicity by an integrated clinical-experimental-computational human hematopoiesis systems toxicology model. Poster at Population Approach Group Europe (PAGE) Meeting (2025).
- M. Mohr, R. Lissilaa, A. Hohlbaum, F. Schmidt. Integrated in vitro/in silico systems immunology model to quantify drug-induced changes in the immune response after influenza A virus infection. Poster at Population Approach Group Europe (PAGE) Meeting (2024).
- M. Mohr, R. Lissilaa, A. Hohlbaum, F. Schmidt. Combining a systems immunology approach with in vitro data to evaluate drug-induced changes in the immune response after influenza A virus infection. Poster at Safety Pharmacology Society Meeting (2023)
- M. Mohr, J. M. Chambard, V. Ballet, F. Schmidt. Modelling of cardiac electrophysiology. Poster at European Conference of Mathematical and Theoretical Biology (2022)
- M. Mohr, V. Ballet, F. Schmidt. Can in silico simulations replace the Purkinje fiber assay in early pharmaceutical cardiosafety assessment? Poster at Safety Pharmacology Society Meeting (2021)
- M. Mohr, D. Hose, A. Seckinger, A. Marciniak-Czochra. Mathematical modeling reveals the dynamics of plasma cells in multiple myeloma. Poster at SMB Annual Meeting (2017)
- A. Seckinger, A. Jauch, M. Emde, S. Beck, M. Mohr, M. Granzow, T. Hielscher, T. Rème, R. Schnettler, N. Fard, K. Hinderhofer, P. T. Pyl, W. Huber, V. Benes, A. Marciniak-Czochra, V. Pantesco, A. D. Ho, B. Klein, J. Hillengass, D. Hose. Asymptomatic multiple myeloma: Background of progression, evolution, and prognosis. Blood 128: 235 (2016)
Populärwissenschaftliche Beiträge
- M. Mohr. Onkologische Mathematik - Wie Kaninchen helfen, Krebs berechnen zu können. Springer Medizin URO-NEWS 28 (7-8), 14-16 (2024), Springer Medizin HNO-Nachrichten 54 (5), 52-54 (2024) und Springer Medizin InFo Hämatologie+Onkologie 27, 48-50 (2024).
- M. Mohr. Berechenbarer Krebs. KlarText - Preis für Wissenschaftskommunikation in Mathematik, Sonderbeilage in DIE ZEIT 41: 28-31 (2017)